Reach Us +1 218 451 2974
Identifying Novel Modulators Of Amyloid Precursor Protein (APP) Processing | 21989
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Identifying novel modulators of amyloid precursor protein (APP) processing

2nd International Conference on Alzheimers Disease and Dementia

Katherine AB Kellett, Darren C Tomlinson and Nigel M Hooper

Posters: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.009

The accumulation of amyloid ?-peptide (A?) into insoluble plaques in the brain is a key event in the pathogenesis of Alzheimer?s Disease. The first step in A? formation is the cleavage of the amyloid precursor protein (APP) by the ?-site APP cleaving enzyme (BACE1). The processing of APP by BACE1 can be regulated by a number of different proteins; in this study we sought to identify proteins that modulate BACE1 cleavage of APP using an siRNA screening approach.An siRNA screen was performed using a protease sub-library to knockdown the expression of a range of different proteases (430 targets) in human embryonic kidney 293 cells expressing an N-terminal alkaline phosphatase tagged APP695 construct (APAPP) and overexpressing BACE1. APP and BACE1 siRNA knockdown were tested as positive controls and a WST-1 cell proliferation assay was used to check cell number. Following siRNA knockdown APP processing was monitored by analysis of conditioned media for alkaline phosphatase activity to measure soluble AP-APP fragments. 25 proteins were identified to significantly affect APP cleavage in the initial screen: 22 positive regulators (decreased APP cleavage) and 3 negative regulators (increased APP cleavage) of APP processing were identified. Of the 22 positive regulators, 5 were selected as potential hit candidates (Neurolysin, Bone Morphogenic Protein 1 (BMP-1), Lipoprotein A (Lpa), Kalikrein-related peptidase 6 (KLK6) and Matrix Metallopeptidase 7 (MMP7)) and were further tested for their effects on APP processing by analysis of sAPP? levels by western blot. Neurolysin, BMP-1, Lpa and MMP7 were shown to not specifically affect BACE processing of APP as determined by analysingsAPP?; KLK6, however, significantly decreasedsAPP?. The effect of siRNA knockdown of KLK6 on APP processing was further investigated by analyzing sAPP?, sAPP? and A? using the Mesoscale Discovery System. KLK6 knockdown significantly decreased sAPP? and also decreased A?38, A?40 and A?42, although not significantly. In addition KLK6 knockdown also decreased sAPP?. These changes were not due to a change in total APP levels, as determined by western blot. These data indicated that KLK6 may affect APP processing and the effect of KLK6 on APP processing warrants further investigation. In addition, we have validated an siRNA screening approach for identifying novel regulators of APP processing.
Katherine Kellett received her PhD from King?s College London in 2005 and has since worked in the laboratory of Professor Nigel Hooper, researching into Alzheimer?s disease and mammalian proteases for the last 9 years. In this time she has worked on two grants funded by Alzheimer?s Research UK and has published 12 papers. Along with the rest of Professor Nigel Hooper?s research group, Kate recently moved her work to the University of Manchester.
Relevant Topics